HICKSVILLE, NY, Nov. 15, 2018 (GLOBE NEWSWIRE) --
via NEWMEDIAWIRE -- Canbiola, Inc. (OTCQB:
CANB), is pleased to announce the Company has been
approved for up-listing its common shares for trading on the OTCQB
Venture Market, a US trading platform that is operated by the OTC
Markets Group in New York. The Company will trade on the
OTCQB under symbol "CANB". Canbiola is a manufacturer of
proprietary CBD non-psychoactive cannabinoid products extracted
from the hemp plant focused on the commercial development of hemp
and CBD-based products for both the medical and consumer
market. Its product line includes hemp oil drops (of various
concentrations), muscle and joint salves, and manufacturing of its
new CBD CryoGel pain relief product.
The OTCQB is the premier marketplace for
entrepreneurial and development stage US and international
companies that are committed to providing a high-quality trading
and information experience for their US investors. To be eligible,
companies must be current in their financial reporting, pass a
minimum bid price test, and undergo an annual company verification
and management certification process. The OTCQB quality standards
provide a strong baseline of transparency, as well as the
technology and regulation to improve the information and trading
experience for investors. The ability to have the Company's shares
electronically transferred between brokerages in the US is
significantly more convenient and reduces the costs incurred in
trading shares. When shares are able to trade electronically,
existing investors benefit from greater liquidity and execution
speeds, while opening the door to new investors that may have been
previously been restricted from the Company's shares.
According to Canbiola’s CEO Marco Alfonsi, "Listing on the OTCQB is
part of a long-term strategy to introduce the Company to a broader
audience and the timing of this listing complements the recent
progress we have made with the release of several new products plus
executing the agreement to acquire its manufacturing facility as a
wholly owned subsidiary thereby directly controlling its own
production.†Mr. Alfonsi added, "We expect our presence on the
OTCQB to further enhance trading liquidity and provide additional
exposure to US and institutional investors who are looking to align
with progressive companies like ours which are focused on
non-opioid-based all natural and organic compound products that
contain 99.9% pure CBD."
Alfonsi concluded, “This is a very exciting time in the world of hemp and CBD and we are passionate about the potential to change people’s lives with our CBD products.â€
About Canbiola, Inc.:
Canbiola, Inc. is a public company trading under symbol CANB.
Canbiola, Inc. is a US Company embarking in the sale of a variety of Cannabidiol (CBD) based products. Canbiola has developed its own line of proprietary products as well as seeking synergistic value through acquisitions in the CBD and the medical cannabis industry. Cannabis is currently federally illegal and has legalized for medical purposes in some form in a limited number of states, but pure CBD products are legal in all 50 states. The company has already launched several products found at www.canbiola.com.
CONTACT INFORMATION:
Canbiola Investor Relations
Email: [email protected]
Phone: (516) 595-9544
Website: http://www.canbiola.com
Follow us on Twitter and Facebook